Abstract

Background: Tranexamic acid (TXA) is an anti-fibrinolytic agent. Its use in primary TKR is supported by many studies that confirmed its efficacy for decreasing blood loss. Cesarean section rates are increasing all over the world. Per partum hemorrhage is one of the most common, life-threatening complications of this procedure. The aim of the study to find out the efficacy of tranexamic acid in decreasing blood loss during and after cesarean section. Methodology: The present study was performed at the Department of Obstetrics and Gynecology of the AL Haramine Hospital, Sylhet, from June 1, 2017, to November 30, 2017. Subjects were eligible for the trial if the fetus was more than 38 weeks estimated gestational age and they required elective CS. Elective CS was defined as CS performed before the onset of labor.